EHDEN Participation (Charité Comprehensive Cancer Center): Difference between revisions
No edit summary |
m (Update categories.) |
||
| Line 26: | Line 26: | ||
<span style="display:none">dataAvailability::not publicly available</span> | <span style="display:none">dataAvailability::not publicly available</span> | ||
<span style="display:none">hasDataAccessInstructions::[https://ethikkommission.charite.de/antraege/antraege_charite_mitarbeitende/ click here to access</span> | <span style="display:none">hasDataAccessInstructions::[https://ethikkommission.charite.de/antraege/antraege_charite_mitarbeitende/ click here to access</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Latest revision as of 12:30, 6 December 2025
Go back to Charité Comprehensive Cancer Center page
The Charité Comprehensive Cancer Center is part of the EHDEN Network of Data Partners.
The European Health Data and Evidence Network (EHDEN) aims to standardize European health data using OMOP-CDM to facilitate research. The project creates a federated network of data sources for easy access by researchers and policymakers. Its goal is to improve healthcare outcomes through better data quality and interoperability.
Primary purpose: Cancer cohort from Charité – Universitätsmedizin Berlin.
Type of information: Unknown.
Data level: regional level.
Number of records: 200,000 patients.
Data range: 2023 onwards.
Data access: not publicly available. Instructions to request data for restricted content click here to access.
Contact information: Click here to access.
